Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive curcumin capsules at a dose of 500 mg twice a day for eight weeks. Curcumin and placebo capsules will be prepared by Dineh Pharm
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with endometriosis whose endometriosis has been confirmed by laparoscopy Women with symptomatic endometriosis Not taking of anti-inflammatory or hormonal medication in the last three months Not having endometrial hypoplasia or neoplasia Women who are married and sexually active
Exclusion criteria
Exclusion criteria: Women who have allergic to ginger plants Women with gallstones, jaundice due to bile duct obstruction, and acute biliary colic Women with gastrointestinal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Painful symptoms of endometriosis. Timepoint: Before the intervention and 8 weeks after starting of intervention. Method of measurement: ENDOPAIN-4D questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before the intervention and 8 weeks after starting the intervention. Method of measurement: EHP-30 questionnaire.;Severity of dysmenorrhea. Timepoint: The first three days of the menstrual cycle before the intervention and then the first three days of the next two cycles. Method of measurement: VAS ruler.;Frequency of analgesic use. Timepoint: During the intervention. Method of measurement: Checklist.;Side effects. Timepoint: During the intervention. Method of measurement: Side effects checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhaneh Goodarzi
Tabriz University of Medical Sciences
Outcome results
None listed